Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes

Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes

Arata Itoh, William M Ridgway Division of Immunology, Allergy and Rheumatology, University of Cincinnati College of Medicine, Cincinnati, OH, USA Abstract: Type 1 diabetes (T1D) is characterized by specific destruction of pancreatic insulin-producing beta cells accompanied by evidence of beta-cell-d...

Descripció completa

Dades bibliogràfiques
Autors principals: Itoh A, Ridgway WM
Format: Article
Idioma:English
Publicat: Dove Medical Press 2017-05-01
Col·lecció:ImmunoTargets and Therapy
Matèries:
Type 1 diabetes
Antigen-specific therapy
Innate immunity
Toll-like receptors
Accés en línia:https://www.dovepress.com/targeting-innate-immunity-to-downmodulate-adaptive-immunity-and-revers-peer-reviewed-article-ITT

Internet

https://www.dovepress.com/targeting-innate-immunity-to-downmodulate-adaptive-immunity-and-revers-peer-reviewed-article-ITT

Ítems similars